Skip to main content
. 2023 Nov 8;165(2):291–299. doi: 10.1007/s11060-023-04482-5

Table 4.

Patient outcome characteristics

Outcome 2008–2009 2018–2019 p value
Management decision among all patients at diagnosis 0.6
 Active monitoring, n (%) 19 (14.7) 29 (18)
 Surgery, n (%) 2 (1.6) 1 (0.6)
 Discharge from outpatient care, n (%) 93 (72.1) 114 (70.8)
 Lost to follow up, n (%) 7 (5.4) 10 (6.2)
 Dead, n (%) 8 (6.2) 7 (4.3)
Number of follow-up scans among patients with initial or resumed* active monitoring within 3 years after diagnosis 0.04
 1, n (%) 16 (12.4) 18 (11.2)
 2, n (%) 0 (0) 11 (6.8)
 3, n (%) 2 (1.6) 4 (2.5)
Management decision at last follow up within 3 years of diagnosis of those under initial or resumed* active monitoring 0.14
 Active monitoring, n (%) 6 (31.5) 18 (54.5)
 Surgery, n (%) 2 (10.5) 4 (12.1)
 Discharge from outpatient care, n (%) 6 (31.5) 9 (27.3)
 Lost to follow up, n (%) 5 (26.3) 2 (6.1)
New meningioma related symptoms among all patients within 3 years after diagnosis, n (%) 2 (1.6) 0 (0) 0.16
Death within first 3 years after diagnosis, n (%) 38 (29.5) 57 (35.4) 0.2

*Total number of patients with follow-up scan may exceed the number of patients initially assigned active monitoring as some patients had their brain rescanned for other causes, where change in meningioma was seen and they were resumed to active monitoring